AtriCure wins 510(k) clearance for anti-clot device
June 15, 2010 by MedCity News
AtriCure Inc. wins 510(k) clearance from the Food & Drug Administration for its AtriClip anti-clot device.
AtriCure Inc. (NSDQ:ATRC) won 510(k) clearance from the Food & Drug Administration for its AtriClip device, which protects against blood clots during heart procedures.
The news sent AtriCure’s stock soaring 17 percent, to $6.13, in early after-hours trading June 14.
The West Chester, Ohio-based company plans an initial launch of the device later this month, with a full commercial release coming in the third quarter, according to a press release.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
Recalls: FDA makes Endologix catheter introducer recall Class I
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
pSivida gains big on buyout rumor
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
Online insurance marketplaces face challenges
Experts fear the online health insurance marketplace will be burdened with tech problems and...
Mirabilis Medica pulls in $13M Series A round for ultrasound fibroid device
Women's health company Mirabilis Medica lands up to $13 million in Series A round to back its...
